Ticker
ITRMCompany Name
ITERUM THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 34.01M | $ 13.06M | 38.4% |
3/31/2025 | $ 32.98M | $ 12.69M | 38.47% |
12/31/2024 | $ 44.59M | $ 24.16M | 54.17% |
9/30/2024 | $ 15.92M | $ 13.44M | 84.4% |
6/30/2024 | $ 14.17M | $ 5.01M | 35.35% |
3/31/2024 | $ 19.63M | $ 7.42M | 37.82% |
12/31/2023 | $ 26.26M | $ 6.11M | 23.25% |
9/30/2023 | $ 39.73M | $ 4.85M | 12.21% |
6/30/2023 | $ 51.02M | $ 13.77M | 26.98% |
3/31/2023 | $ 58.12M | $ 16.86M | 29.02% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ITERUM THERAPEUTICS PLC is calculated as follows: CashnEq [ $ 8.63M ] / Assets [ $ 26.27M ]
(=) Cash to Assets [ 32.85% ]
Minimum
Jun 30, 2022
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |